ZYGOMED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ZYGOMED
Largest movements
- Receivables within one year +€134,419
new in 2025: €134,419
of which Other amounts receivable: +€131,419
- Cash -€46,775
down €46,775 (-28.6%), from €163,270 to €116,495
mainly Receivables within one year (-€134,419) and Contributions, distributions and other (-€122,174)
- Deferred charges and accrued income +€6,604
up €6,604 (+96.9%), from €6,815 to €13,419
- Tangible fixed assets -€5,339
down €5,339 (-17.5%), from €30,447 to €25,108
of which Plant, machinery and equipment: -€8,380
- Total equity and liabilities +€88,909
up €88,909 (+44.3%), from €200,531 to €289,440
of which Equity: +€114,940
- Gross operating margin +€7,495
up €7,495 (+4.4%), from €170,040 to €177,535
- Taxes +€3,207
up €3,207 (+8.9%), from €36,199 to €39,406
- Financial income +€2,074
up €2,074 (+2,960%), from €70 to €2,144
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €200,531 | €289,440 | +€88,909 | +44.3% |
| Fixed assets | 21/28 | €30,447 | €25,108 | -€5,339 | -17.5% |
| Tangible fixed assets | 22/27 | €30,447 | €25,108 | -€5,339 | -17.5% |
| Land and buildings | 22 | - | €6,900 | +€6,900 | |
| Plant, machinery and equipment | 23 | €15,842 | €7,462 | -€8,380 | -52.9% |
| Furniture and vehicles | 24 | €14,604 | €10,746 | -€3,858 | -26.4% |
| Current assets | 29/58 | €170,084 | €264,332 | +€94,248 | +55.4% |
| Amounts receivable within one year | 40/41 | - | €134,419 | +€134,419 | |
| Trade receivables | 40 | - | €3,000 | +€3,000 | |
| Other amounts receivable | 41 | - | €131,419 | +€131,419 | |
| Cash at bank and in hand | 54/58 | €163,270 | €116,495 | -€46,775 | -28.6% |
| Deferred charges and accrued income | 490/1 | €6,815 | €13,419 | +€6,604 | +96.9% |
| Total equity and liabilities | 10/49 | €200,531 | €289,440 | +€88,909 | +44.3% |
| Equity | 10/15 | €120,529 | €235,468 | +€114,940 | +95.4% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €116,529 | €231,468 | +€114,940 | +98.6% |
| Amounts payable | 17/49 | €87,236 | €53,972 | -€33,264 | -38.1% |
| Amounts payable within one year | 42/48 | €87,236 | €47,572 | -€39,664 | -45.5% |
| Trade debts | 44 | €1,422 | €8,269 | +€6,847 | +481% |
| Suppliers | 440/4 | €1,422 | €8,269 | +€6,847 | +481% |
| Taxes, remuneration and social security | 45 | €37,269 | €39,303 | +€2,034 | +5.5% |
| Taxes | 450/3 | €37,269 | €39,303 | +€2,034 | +5.5% |
| Other amounts payable | 47/48 | €49,503 | - | -€49,503 | |
| Accrued charges and deferred income | 492/3 | - | €6,400 | +€6,400 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €15,844 | €16,917 | +€1,072 | +6.8% |
| Other operating charges | 640/8 | €1,379 | €950 | -€429 | -31.1% |
| Gross operating margin | 9900 | €170,040 | €177,535 | +€7,495 | +4.4% |
| Operating profit (loss) | 9901 | €152,817 | €159,669 | +€6,852 | +4.5% |
| Financial income | 75/76B | €70 | €2,144 | +€2,074 | +2,960% |
| Recurring financial income | 75 | €70 | €2,144 | +€2,074 | +2,960% |
| Financial charges | 65/66B | €159 | €232 | +€74 | +46.6% |
| Recurring financial charges | 65 | €159 | €232 | +€74 | +46.6% |
| Profit (loss) for the period before taxes | 9903 | €152,728 | €161,580 | +€8,852 | +5.8% |
| Income taxes | 67/77 | €36,199 | €39,406 | +€3,207 | +8.9% |
| Profit (loss) for the period | 9904 | €116,529 | €122,174 | +€5,645 | +4.8% |
| Profit (loss) for the period to be appropriated | 9905 | €116,529 | €122,174 | +€5,645 | +4.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.